TH-302
Description: TH-302, also called evofosfamide, is a hypoxia-activated prodrug investigated as an anticancer treatment for solid tumors.
Primary topic: Cancer, Hypoxia, and Metabolism (31%)
Wikidata ID: wiki/Q7670203
OpenAlex ID: keywords/th-302
